Yoshito Ogihara1, Norikazu Yamada2, Kaoru Dohi3, Akimasa Matsuda1, Akihiro Tsuji1, Satoshi Ota1, Ken Ishikura1, Mashio Nakamura4, Masaaki Ito1. 1. Department of Cardiology and Nephrology, Mie University Graduate School of Medicine, Tsu, Mie, Japan. 2. Department of Cardiology and Nephrology, Mie University Graduate School of Medicine, Tsu, Mie, Japan. Electronic address: n-yamada@clin.medic.mie-u.ac.jp. 3. Department of Molecular and Laboratory Medicine, Mie University Graduate School of Medicine, Tsu, Mie, Japan. 4. Department of Clinical Cardiovascular Research, Mie University Graduate School of Medicine, Tsu, Mie, Japan.
Abstract
BACKGROUND: We sought to evaluate the potential utility of echocardiography-derived morphological and functional right ventricular (RV) variables for assessing disease severity of pulmonary arterial hypertension (PAH) and determining the changes in the patient's hemodynamics in the clinical course. METHODS AND RESULTS: This study consisted of 24 normal controls (the control group) and 24 patients with PAH at rest or with exercise (the PAH group) who underwent echocardiography, right heart catheterization, plasma brain natriuretic peptide (BNP) measurement, and six-minute walk distance (6MWD) test. The PAH group had poorer RV echocardiographic variables than the control group. RV Tei-index was more strongly correlated with 6MWD, BNP, cardiac index, mean pulmonary arterial pressure, and pulmonary vascular resistance (PVR) than other RV echocardiography-derived variables including RV end-diastolic areas, RV fractional area change, and tricuspid annular plane systolic excursion. In 16 of the 24 patients who successfully underwent repeated examination during follow up (13.3 ± 4.9 months; range, 5-24 months), PVR decreased from 486 ± 380 dynes cm(-5) to 346 ± 252 dynes cm(-5), and RV Tei-index decreased from 0.55 ± 0.30 to 0.42 ± 0.17, and the changes in RV Tei-index were correlated with the concomitant changes in PVR during the clinical course of PAH (r=0.706, p=0.002). Tricuspid annular plane systolic excursion and RV fractional area change did not change during the follow up. CONCLUSIONS: Quantitative echocardiography revealed that the measurement of RV Tei-index is of great clinical utility for predicting disease severity of PAH and determining the changes in the patient's hemodynamics in the clinical course.
BACKGROUND: We sought to evaluate the potential utility of echocardiography-derived morphological and functional right ventricular (RV) variables for assessing disease severity of pulmonary arterial hypertension (PAH) and determining the changes in the patient's hemodynamics in the clinical course. METHODS AND RESULTS: This study consisted of 24 normal controls (the control group) and 24 patients with PAH at rest or with exercise (the PAH group) who underwent echocardiography, right heart catheterization, plasma brain natriuretic peptide (BNP) measurement, and six-minute walk distance (6MWD) test. The PAH group had poorer RV echocardiographic variables than the control group. RV Tei-index was more strongly correlated with 6MWD, BNP, cardiac index, mean pulmonary arterial pressure, and pulmonary vascular resistance (PVR) than other RV echocardiography-derived variables including RV end-diastolic areas, RV fractional area change, and tricuspid annular plane systolic excursion. In 16 of the 24 patients who successfully underwent repeated examination during follow up (13.3 ± 4.9 months; range, 5-24 months), PVR decreased from 486 ± 380 dynes cm(-5) to 346 ± 252 dynes cm(-5), and RV Tei-index decreased from 0.55 ± 0.30 to 0.42 ± 0.17, and the changes in RV Tei-index were correlated with the concomitant changes in PVR during the clinical course of PAH (r=0.706, p=0.002). Tricuspid annular plane systolic excursion and RV fractional area change did not change during the follow up. CONCLUSIONS: Quantitative echocardiography revealed that the measurement of RV Tei-index is of great clinical utility for predicting disease severity of PAH and determining the changes in the patient's hemodynamics in the clinical course.
Authors: Richard M Friesen; Michal Schäfer; Dale A Burkett; Courtney J Cassidy; D Dunbar Ivy; Pei-Ni Jone Journal: Pediatr Cardiol Date: 2017-10-04 Impact factor: 1.655
Authors: Christopher John Boos; John Paul O'Hara; Adrian Mellor; Peter David Hodkinson; Costas Tsakirides; Nicola Reeve; Liam Gallagher; Nicholas Donald Charles Green; David Richard Woods Journal: PLoS One Date: 2016-04-21 Impact factor: 3.240
Authors: Zuzanna Lewicka-Potocka; Alicja Dąbrowska-Kugacka; Ewa Lewicka; Rafał Gałąska; Ludmiła Daniłowicz-Szymanowicz; Anna Faran; Izabela Nabiałek-Trojanowska; Marcin Kubik; Anna Maria Kaleta-Duss; Grzegorz Raczak Journal: Int J Environ Res Public Health Date: 2020-07-24 Impact factor: 3.390
Authors: Rebecca R Vanderpool; Reena Puri; Alexandra Osorio; Kelly Wickstrom; Ankit Desai; Stephen Black; Joe G N Garcia; Jason Yuan; Franz Rischard Journal: Pulm Circ Date: 2019-04-29 Impact factor: 3.017